Cargando…
Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report
BACKGROUND: Rituximab is a monoclonal antibody inducing depletion of B lymphocytes and presently approved for the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. Here is the first report of the use of this drug in a case of Cogan's syndrome (CS). CASE PRESENTATION: a 25-year-...
Autores principales: | Orsoni, Jelka G, Laganà, Bruno, Rubino, Pierangela, Zavota, Laura, Bacciu, Salvatore, Mora, Paolo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907322/ https://www.ncbi.nlm.nih.gov/pubmed/20550723 http://dx.doi.org/10.1186/1750-1172-5-18 |
Ejemplares similares
-
Altered Brain Glucose Consumption in Cogan's Syndrome
por: Mora, Paolo, et al.
Publicado: (2016) -
Rituximab Not Effective for Hearing Loss in Cogan's Syndrome
por: Bunker, Daniel R., et al.
Publicado: (2016) -
Factitious Pseudo-Membranous Conjunctivitis in an Adolescent Boy
por: Orsoni, Jelka G., et al.
Publicado: (2011) -
Staphylococcus aureus and autoimmune uveitis reactivation in childhood: a possible correlation?
por: Mora, Paolo, et al.
Publicado: (2009) -
Anterior Segment Findings in Vitamin A Deficiency: A Case Series
por: Rubino, Pierangela, et al.
Publicado: (2015)